As compared to the lead compound, the novel complexes not only could reduce the upregulated VEGF expression from cancer cells as well as inhibit the activation of VEGFR2 and downstream proteins of vascular endothelial cells, but they could also suppress endothelial cell migration and new vessel formation [89]. This evidence concerns the gene KDR and cancer.